Cell Death Dis 8 , e2848 (2017)
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
A blood test tells you whether you are actually low, so you are treating a real need, not guessing
(PubMed) van Dam DG, Beijers AJ, Vreugdenhil G
[13] DSIP and Muscle Cells Delta Sleep-Inducing Peptide was first discovered in the brains of rabbits during slow-wave sleep and has since been involved with sleep research and central nervous system-mediated control of sleep-wake cycles